United States · FDA National Drug Code directory
VOYXACT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59148-400_9aa886b0-669e-48d4-9f37-a160d78f69c6
- Product NDC
- 59148-400
- Form
- INJECTION
- Composition / generic term
- sibeprenlimab
- Labeler
- Otsuka America Pharmaceutical, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20251125
- Source listing expiry
- 20271231
Source-listed ingredients
- SIBEPRENLIMAB — 200 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (59148-400-75) / 2 mL in 1 SYRINGE · 59148-400-75
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →